跳至主要内容
临床试验/JPRN-UMIN000008451
JPRN-UMIN000008451已完成未知

Randomized Controlled Trial of mirtazapine vs lithium as augmentation after SSRI/SNRI failure. - Mirtazapin Effectiveness for Treatment Resistant depressION (METRION)

Kansai Medical University Department of Neuropsychiatry0 个研究点目标入组 50 人开始时间: 2012年7月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Subjects with clinically significant unstable medical illness, pregnancy, a principal psychiatric diagnosis other than major depression, a history of substance abuse or dependence active within the previous 6 months, and electroconvulsive therapy within the previous 6 months were excluded. Subjects with axis I disorder other than major depressive disorder and personality disorder was also excluded.

研究者

发起方
Kansai Medical University Department of Neuropsychiatry

相似试验